GHRP-6
Growth Hormone Releasing Peptide-6, Growth hormone-releasing hexapeptide, His-D-Trp-Ala-Trp-D-Phe-Lys-NH2
Growth hormone-releasing peptide (GHRP).
Bowers. C Y CY
Key Findings
- GHRPs stimulate GH release through a dual action on hypothalamus and pituitary.
- Current GHRPs are synthetic but may imitate a natural hypothalamic hormone that hasn’t been isolated yet.
- They have potential diagnostic and therapeutic applications in humans.
Practical Outcomes
- For biohackers, the main takeaway is that GHRP‑6 can boost growth hormone levels, but the study provides no concrete dosing or safety guidance. Use this information as a conceptual basis and look for more detailed, protocol‑focused research before trying it.
Summary
Growth hormone‑releasing peptides (GHRPs) like GHRP‑6 are man‑made compounds that trigger the body to release more growth hormone by acting on both the brain (hypothalamus) and the pituitary gland. Scientists think they may mimic a yet‑to‑be‑found natural hormone. While they show promise for medical testing and therapy, the abstract doesn’t give specific dosing or protocol details.
Abstract
Growth hormone-releasing peptides and non-peptides (GHRPs. GHRP-GHS) are a new chemical class of GH secretagogues with a chemistry that ranges from small synthetic peptides to peptidomimetics. They release GH in animals and humans by a unique dual and complementary action on the hypothalamus and pituitary. Although the present GHRPs are of unnatural origin, evidence by a number of investigators is gradually accumulating to support that GHRP reflects the GH-releasing action of a new natural hypothalamic hormone yet to be isolated and identified. Despite the de novo origin of GHRP, a major reason for the persistent investigation is because of the possible practical diagnostic and therapeutic value in humans as well as the potential theoretical value of new insight into the physiological regulation of GH secretion.
Study Information
pubmed
1998
1998-12-01T00:00:00.000Z
10.1007/s000180050257
158
55